ICD-10-CM › T
ICD-10-CM codes starting with T
14,751 codes, page 59 of 148. Every code ever valid for billing is listed, including those now retired.
| Code | Description | Status |
|---|---|---|
| T40.715A | Adverse effect of cannabis, initial encounter | Valid |
| T40.715D | Adverse effect of cannabis, subsequent encounter | Valid |
| T40.715S | Adverse effect of cannabis, sequela | Valid |
| T40.716 | Underdosing of cannabis | Not billable |
| T40.716A | Underdosing of cannabis, initial encounter | Valid |
| T40.716D | Underdosing of cannabis, subsequent encounter | Valid |
| T40.716S | Underdosing of cannabis, sequela | Valid |
| T40.72 | Poisoning by, adverse effect of and underdosing of synthetic cannabinoids | Not billable |
| T40.721 | Poisoning by synthetic cannabinoids, accidental (unintentional) | Not billable |
| T40.721A | Poisoning by synthetic cannabinoids, accidental (unintentional), initial encounter | Valid |
| T40.721D | Poisoning by synthetic cannabinoids, accidental (unintentional), subsequent encounter | Valid |
| T40.721S | Poisoning by synthetic cannabinoids, accidental (unintentional), sequela | Valid |
| T40.722 | Poisoning by synthetic cannabinoids, intentional self-harm | Not billable |
| T40.722A | Poisoning by synthetic cannabinoids, intentional self-harm, initial encounter | Valid |
| T40.722D | Poisoning by synthetic cannabinoids, intentional self-harm, subsequent encounter | Valid |
| T40.722S | Poisoning by synthetic cannabinoids, intentional self-harm, sequela | Valid |
| T40.723 | Poisoning by synthetic cannabinoids, assault | Not billable |
| T40.723A | Poisoning by synthetic cannabinoids, assault, initial encounter | Valid |
| T40.723D | Poisoning by synthetic cannabinoids, assault, subsequent encounter | Valid |
| T40.723S | Poisoning by synthetic cannabinoids, assault, sequela | Valid |
| T40.724 | Poisoning by synthetic cannabinoids, undetermined | Not billable |
| T40.724A | Poisoning by synthetic cannabinoids, undetermined, initial encounter | Valid |
| T40.724D | Poisoning by synthetic cannabinoids, undetermined, subsequent encounter | Valid |
| T40.724S | Poisoning by synthetic cannabinoids, undetermined, sequela | Valid |
| T40.725 | Adverse effect of synthetic cannabinoids | Not billable |
| T40.725A | Adverse effect of synthetic cannabinoids, initial encounter | Valid |
| T40.725D | Adverse effect of synthetic cannabinoids, subsequent encounter | Valid |
| T40.725S | Adverse effect of synthetic cannabinoids, sequela | Valid |
| T40.726 | Underdosing of synthetic cannabinoids | Not billable |
| T40.726A | Underdosing of synthetic cannabinoids, initial encounter | Valid |
| T40.726D | Underdosing of synthetic cannabinoids, subsequent encounter | Valid |
| T40.726S | Underdosing of synthetic cannabinoids, sequela | Valid |
| T40.7X | Poisoning by, adverse effect of and underdosing of cannabis (derivatives) through FY2021 | Retired |
| T40.7X1 | Poisoning by cannabis (derivatives), accidental (unintentional) through FY2021 | Retired |
| T40.7X1A | Poisoning by cannabis (derivatives), accidental (unintentional), initial encounter through FY2021 | Retired |
| T40.7X1D | Poisoning by cannabis (derivatives), accidental (unintentional), subsequent encounter through FY2021 | Retired |
| T40.7X1S | Poisoning by cannabis (derivatives), accidental (unintentional), sequela through FY2021 | Retired |
| T40.7X2 | Poisoning by cannabis (derivatives), intentional self-harm through FY2021 | Retired |
| T40.7X2A | Poisoning by cannabis (derivatives), intentional self-harm, initial encounter through FY2021 | Retired |
| T40.7X2D | Poisoning by cannabis (derivatives), intentional self-harm, subsequent encounter through FY2021 | Retired |
| T40.7X2S | Poisoning by cannabis (derivatives), intentional self-harm, sequela through FY2021 | Retired |
| T40.7X3 | Poisoning by cannabis (derivatives), assault through FY2021 | Retired |
| T40.7X3A | Poisoning by cannabis (derivatives), assault, initial encounter through FY2021 | Retired |
| T40.7X3D | Poisoning by cannabis (derivatives), assault, subsequent encounter through FY2021 | Retired |
| T40.7X3S | Poisoning by cannabis (derivatives), assault, sequela through FY2021 | Retired |
| T40.7X4 | Poisoning by cannabis (derivatives), undetermined through FY2021 | Retired |
| T40.7X4A | Poisoning by cannabis (derivatives), undetermined, initial encounter through FY2021 | Retired |
| T40.7X4D | Poisoning by cannabis (derivatives), undetermined, subsequent encounter through FY2021 | Retired |
| T40.7X4S | Poisoning by cannabis (derivatives), undetermined, sequela through FY2021 | Retired |
| T40.7X5 | Adverse effect of cannabis (derivatives) through FY2021 | Retired |
| T40.7X5A | Adverse effect of cannabis (derivatives), initial encounter through FY2021 | Retired |
| T40.7X5D | Adverse effect of cannabis (derivatives), subsequent encounter through FY2021 | Retired |
| T40.7X5S | Adverse effect of cannabis (derivatives), sequela through FY2021 | Retired |
| T40.7X6 | Underdosing of cannabis (derivatives) through FY2021 | Retired |
| T40.7X6A | Underdosing of cannabis (derivatives), initial encounter through FY2021 | Retired |
| T40.7X6D | Underdosing of cannabis (derivatives), subsequent encounter through FY2021 | Retired |
| T40.7X6S | Underdosing of cannabis (derivatives), sequela through FY2021 | Retired |
| T40.8 | Poisoning by and adverse effect of lysergide [LSD] | Not billable |
| T40.8X | Poisoning by and adverse effect of lysergide [LSD] | Not billable |
| T40.8X1 | Poisoning by lysergide [LSD], accidental (unintentional) | Not billable |
| T40.8X1A | Poisoning by lysergide [LSD], accidental (unintentional), initial encounter | Valid |
| T40.8X1D | Poisoning by lysergide [LSD], accidental (unintentional), subsequent encounter | Valid |
| T40.8X1S | Poisoning by lysergide [LSD], accidental (unintentional), sequela | Valid |
| T40.8X2 | Poisoning by lysergide [LSD], intentional self-harm | Not billable |
| T40.8X2A | Poisoning by lysergide [LSD], intentional self-harm, initial encounter | Valid |
| T40.8X2D | Poisoning by lysergide [LSD], intentional self-harm, subsequent encounter | Valid |
| T40.8X2S | Poisoning by lysergide [LSD], intentional self-harm, sequela | Valid |
| T40.8X3 | Poisoning by lysergide [LSD], assault | Not billable |
| T40.8X3A | Poisoning by lysergide [LSD], assault, initial encounter | Valid |
| T40.8X3D | Poisoning by lysergide [LSD], assault, subsequent encounter | Valid |
| T40.8X3S | Poisoning by lysergide [LSD], assault, sequela | Valid |
| T40.8X4 | Poisoning by lysergide [LSD], undetermined | Not billable |
| T40.8X4A | Poisoning by lysergide [LSD], undetermined, initial encounter | Valid |
| T40.8X4D | Poisoning by lysergide [LSD], undetermined, subsequent encounter | Valid |
| T40.8X4S | Poisoning by lysergide [LSD], undetermined, sequela | Valid |
| T40.9 | Poisoning by, adverse effect of and underdosing of other and unspecified psychodysleptics [hallucinogens] | Not billable |
| T40.90 | Poisoning by, adverse effect of and underdosing of unspecified psychodysleptics [hallucinogens] | Not billable |
| T40.901 | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional) | Not billable |
| T40.901A | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), initial encounter | Valid |
| T40.901D | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), subsequent encounter | Valid |
| T40.901S | Poisoning by unspecified psychodysleptics [hallucinogens], accidental (unintentional), sequela | Valid |
| T40.902 | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm | Not billable |
| T40.902A | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, initial encounter | Valid |
| T40.902D | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, subsequent encounter | Valid |
| T40.902S | Poisoning by unspecified psychodysleptics [hallucinogens], intentional self-harm, sequela | Valid |
| T40.903 | Poisoning by unspecified psychodysleptics [hallucinogens], assault | Not billable |
| T40.903A | Poisoning by unspecified psychodysleptics [hallucinogens], assault, initial encounter | Valid |
| T40.903D | Poisoning by unspecified psychodysleptics [hallucinogens], assault, subsequent encounter | Valid |
| T40.903S | Poisoning by unspecified psychodysleptics [hallucinogens], assault, sequela | Valid |
| T40.904 | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined | Not billable |
| T40.904A | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, initial encounter | Valid |
| T40.904D | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, subsequent encounter | Valid |
| T40.904S | Poisoning by unspecified psychodysleptics [hallucinogens], undetermined, sequela | Valid |
| T40.905 | Adverse effect of unspecified psychodysleptics [hallucinogens] | Not billable |
| T40.905A | Adverse effect of unspecified psychodysleptics [hallucinogens], initial encounter | Valid |
| T40.905D | Adverse effect of unspecified psychodysleptics [hallucinogens], subsequent encounter | Valid |
| T40.905S | Adverse effect of unspecified psychodysleptics [hallucinogens], sequela | Valid |
| T40.906 | Underdosing of unspecified psychodysleptics [hallucinogens] | Not billable |
| T40.906A | Underdosing of unspecified psychodysleptics [hallucinogens], initial encounter | Valid |
| T40.906D | Underdosing of unspecified psychodysleptics [hallucinogens], subsequent encounter | Valid |